![Maggie Flanagan LeFlore](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Maggie Flanagan LeFlore
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Maggie Flanagan LeFlore
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
MedImmune Ventures, Inc.
![]() MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland.
9
| Subsidiary | Investment Managers | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Maggie Flanagan LeFlore
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Centocor, Inc.
![]() Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal | |
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Director/Board Member President President Corporate Officer/Principal | |
US Healthcare, Inc.
![]() US Healthcare, Inc. Medical/Nursing ServicesHealth Services Part of CVS Health Corp., US Healthcare, Inc. is a company that provides healthcare services for individuals, families, and businesses. US Healthcare, Inc. is based in Blue Bell, PA. US Healthcare was acquired by Aetna, Inc., part of CVS Health Corp. from November 29, 2018 on July 19, 1996 for $8,114.05 million. The company was founded by Benad Goldwasser, Angelo Masciantonio. | Medical/Nursing Services | Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
VIVUS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
GENVEC INC | Pharmaceuticals: Major | Chairman | |
NEOGENOMICS, INC. | Medical/Nursing Services | Director/Board Member | |
Hallmark Cards, Inc.
![]() Hallmark Cards, Inc. Consumer SundriesConsumer Non-Durables Hallmark Cards, Inc. sells greeting card products, art supplies and stationery to retail outlets. It offers greeting cards, holiday cards, gift wrap, story books, ornaments and stationary products. The firm offers art tools, crafting activities, and creative toys for kids. The company was founded by Joyce Clyde Hall in 1910 and is headquartered in Kansas City, MO. | Consumer Sundries | Corporate Officer/Principal | |
MERSANA THERAPEUTICS, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Zyngenia, Inc.
![]() Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Chairman Founder | |
BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
Ziarco, Inc. | Director/Board Member | ||
NEA Management Co. LLC
![]() NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Frostburg State University | College/University | Undergraduate Degree | |
The Pennsylvania State University | College/University | Undergraduate Degree | |
St. Joseph's University | College/University | Masters Business Admin | |
Western Connecticut State University | College/University | Undergraduate Degree | |
American Cancer Society, Inc.
![]() American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AstraZeneca Pharmaceuticals LP
![]() AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | President | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Healthcare Leadership Council
![]() Healthcare Leadership Council Medical/Nursing ServicesHealth Services Healthcare Leadership Council operates as a organization focusing on the provision of a healthcare system. The company is headquartered in Washington, DC. | Medical/Nursing Services | Director/Board Member | |
National Pharmaceutical Council
![]() National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
First State Innovation, Inc.
![]() First State Innovation, Inc. Financial ConglomeratesFinance First State Innovation, Inc. provides investment services to technology-based and early stage businesses. It services include seed capital, alternative funding, skilled human capital, commercialization assistance, intellectual capital and other entrepreneurial resource services. The firm also provides biotechnology and life sciences, advanced materials, information technology, nanotechnology, financial services and supporting infrastructure. The company was founded in 2006 and is headquartered in Wilmington, DE. | Financial Conglomerates | Director/Board Member | |
Praxis Biologics, Inc.
![]() Praxis Biologics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Praxis Biologics, Inc. manufactures vaccines and injectable biologic medicines. The company is based in Rochester, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
INHIBIKASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Altherx, Inc.
![]() Altherx, Inc. Medical/Nursing ServicesHealth Services Altherx, Inc. operates as a clinical development company. The company was founded on May 11, 2010 and is headquartered in Glenmoore, PA. | Medical/Nursing Services | Director/Board Member | |
Biohealth Innovation, Inc.
![]() Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Financial Conglomerates | Director/Board Member Director/Board Member | |
INNOCOLL HOLDINGS PLC | Pharmaceuticals: Major | Chief Executive Officer | |
SpliceBio SL
![]() SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Inversago Pharma, Inc.
![]() Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Shape Therapeutics, Inc.
![]() Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Shape Therapeutics, Inc. operates as a biotechnology firm. It offers genome medicine. The company was founded by Francois Vigneault and John D. Suliman in 2018 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Voltron Therapeutics, Inc.
![]() Voltron Therapeutics, Inc. BiotechnologyHealth Technology Voltron Therapeutics, Inc. develops the vaccine and immunotherapy center. The company was founded in 2017 and is headquartered in New York, NY. | Biotechnology | Chairman | |
Algorithm Sciences, Inc.
![]() Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Algorithm Sciences, Inc. engages in the business of technology services. The company was founded in 2019 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman | |
Viralclear Pharmaceuticals, Inc.
![]() Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Director/Board Member | |
Code Biotherapeutics, Inc.
![]() Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Affinia Therapeutics, Inc.
![]() Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
MBX Biosciences, Inc.
![]() MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member | |
Sorriso Pharmaceuticals, Inc.
![]() Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Sorriso Pharmaceuticals, Inc. is an American biotechnology company that focuses on developing disease-modifying antibodies to treat inflammatory diseases. Sorriso Pharmaceuticals was founded by Ciara Kennedy, who has been the CEO since its incorporation. | Biotechnology | Director/Board Member |
Statistik
International
Vereinigte Staaten | 44 |
Vereinigtes Königreich | 2 |
Irland | 2 |
Spanien | 2 |
Kanada | 2 |
Sektoral
Health Technology | 28 |
Health Services | 5 |
Commercial Services | 5 |
Consumer Services | 5 |
Finance | 4 |
Operativ
Director/Board Member | 130 |
Independent Dir/Board Member | 35 |
Chairman | 29 |
Corporate Officer/Principal | 27 |
Chief Executive Officer | 13 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Ed Mathers Mathers | 47 |
David Mott | 45 |
Peter Greenleaf | 31 |
Anthony Zook | 24 |
Wayne T. Hockmeyer | 22 |
Tyrell J. Rivers | 17 |
Joseph Amprey | 9 |
Franklin H. Top | 8 |
Eva M. Jack | 7 |
- Börse
- Insiders
- Maggie Flanagan LeFlore
- Unternehmensverbindungen